Pharma Grade Sesame Oil Market Size, Production, Sales, Average Product Price, Market Share, Import vs Export 

Emerging Trends in Pharma Grade Sesame Oil Market 

The Pharma Grade Sesame Oil Market has been undergoing significant evolution in recent years, driven by rising applications in pharmaceutical formulations, nutraceuticals, and as a carrier oil in injectables. Demand is being shaped by an increasing preference for natural, plant-based excipients, the expansion of chronic disease treatments, and the parallel growth of herbal and Ayurvedic medicine practices worldwide. According to Datavagyanik, this market transformation signifies not only an expansion in size but also a structural shift in its direction, with companies exploring new use cases that were previously untapped. 

 

Rising Application of Pharma Grade Sesame Oil in Drug Formulations 

One of the strongest drivers reshaping the Pharma Grade Sesame Oil Market is its growing use in drug formulations, particularly in injection-based medications and oil-soluble drugs. For instance, sesame oil serves as an effective carrier for lipophilic active pharmaceutical ingredients (APIs) such as fat-soluble vitamins, hormones, and steroids. Its natural antioxidant properties, coupled with stability at room temperature, make it superior to several synthetic alternatives. For example, vitamin D and vitamin E formulations have increasingly relied on sesame oil for better stability and absorbability, fueling new demand across both developed and emerging pharmaceutical hubs. 

The increasing production and demand for parenteral formulations has had a direct impact on sesame oil usage. Injectable formulations with sustained and controlled release properties are particularly growing at a consistent pace, creating new opportunities across major pharmaceutical markets. 

 

The Pharma Grade Sesame Oil Market Size and Path of Expansion 

The Pharma Grade Sesame Oil Market Size has already crossed the multi-million-dollar benchmark, with steady year-on-year growth reflecting its long-term potential. According to Datavagyanik, the next five years will likely witness growth rates in the range of 6% to 8% CAGR, reflecting robust demand from different application segments. Such expansion is not only due to classic pharmaceutical usage but also due to proliferating alternative therapy practices such as Ayurveda, Traditional Chinese Medicine, and integrative medicine in Western countries. 

For instance, Ayurvedic drugs contribute to more than 40% of sesame oil consumption in pharma-grade quality in India, and similar patterns are emerging in global markets such as Europe and North America. As consumer demand for natural therapies continues to grow, sesame oil’s role as a base medium for medicinal oil preparations will become increasingly prominent. 

 

Growth Drivers from Injectable Segment in Pharma Grade Sesame Oil Market 

The parenteral drug delivery segment is one of the strongest growth engines for the Pharma Grade Sesame Oil Market. Injectable solutions often require highly purified, stable oils, and sesame oil fulfills these needs efficiently. For example, hormones like progesterone and testosterone are often prepared in sesame oil-based injection solutions to improve absorption rates. Demand is further magnified by increasing fertility treatments, hormone replacement therapies, and the rising prevalence of endocrine disorders worldwide. 

Fertility clinics in Europe, for instance, report steady year-on-year growth in treatment volumes, directly expanding the demand pool for pharmaceutical sesame oil applications. The market’s ability to capture such high-value sectors ensures continued long-term growth prospects. 

 

Expanding Role in Nutraceuticals and Functional Medicine 

Apart from parenteral use, the Pharma Grade Sesame Oil Market is also driven by changing consumer patterns toward nutraceuticals and dietary supplements. The oil is used as a carrier ingredient in antioxidant-rich formulations and as an essential base in omega and vitamin blends. Nutraceutical demand itself has shown double-digit growth rates in key regions such as North America, Europe, and Asia-Pacific, resulting in a multiplier effect on sesame oil consumption. 

For example, the U.S. nutraceutical market is witnessing more than 10% annual growth, and sesame oil, as a natural excipient, stands at the intersection of drug formulations and food-grade supplements. This multi-sector utility uniquely positions the market to grow sustainably beyond pharmaceutical boundaries. 

 

Pharma Grade Sesame Oil Market in Ayurveda and Herbal Medicines 

Sesame oil has been foundational in Ayurvedic therapies for thousands of years, and its transition into modern pharmaceutical ecosystems has been seamless. The Pharma Grade Sesame Oil Market is set to benefit considerably from the global resurgence of Ayurveda and traditional holistic practices. For instance, multinational formulators are increasingly sourcing pharma-grade sesame oil for producing Ayurvedic medicines that are being commercialized across international markets. 

The transition of these therapies into regulated product categories, especially under nutraceutical and complementary medicine frameworks in Europe, is projected to drive double-digit annual growth in Ayurvedic oil-based products. This trend ensures that sesame oil will not just remain an excipient but will further emerge as a central enabler of natural and plant-based therapies. 

 

Comparison with Synthetic Alternatives in Pharma Grade Sesame Oil Market 

One of the defining shifts in the Pharma Grade Sesame Oil Market is the preference for natural oils over synthetic or mineral oils. Factors such as biocompatibility, fewer side effects, and enhanced stability have positioned sesame oil as a superior option. For example, mineral oil-based carriers are finding reduced acceptance in newer product pipelines, while pharma-grade sesame oil enjoys wider compliance recognition, particularly in regulated markets such as Europe and the United States. 

This preference shift is influenced not only by regulatory compliance but also by consumer sentiment. A growing proportion of patients and healthcare consumers prefer natural, plant-derived ingredients in medicinal formulations, aligning with global clean-label trends. 

 

Strong Growth Across Emerging Markets 

The expansion of pharmaceutical industries in emerging regions such as India, China, and Southeast Asia is strongly influencing the Pharma Grade Sesame Oil Market. For example, India alone accounts for a significant share of global sesame oil-based formulations due to both modern pharma production and Ayurvedic formulations. Similarly, China is witnessing rapid adoption in Traditional Chinese Medicine (TCM) and integrative healthcare formats. 

In Africa and the Middle East, the growing demand for plant-based excipients and the rise in oilseed crop cultivation are expected to further expand sesame oil’s pharmaceutical footprint. This geographical broadening ensures a balanced global growth outlook, reducing dependency on a few mature markets. 

 

Pharma Grade Sesame Oil Market Driven by Chronic Diseases Growth 

The prevalence of chronic conditions such as diabetes, cardiovascular disease, and arthritis is directly enhancing demand for long-term therapies, where sesame oil is frequently used as an excipient. For example, omega-rich injectable blends and sustained-release injectable formulations used in treating cholesterol imbalances often rely on sesame oil. The Pharma Grade Sesame Oil Market therefore benefits from both the rising patient base and the extension of treatment durations. 

By 2030, chronic disease treatment expenditures are projected to form more than 60% of healthcare spending in developed economies, which will, in turn, accelerate the consumption of high-purity excipients like pharmaceutical sesame oil. 

“Track Country-wise Pharma Grade Sesame Oil Production and Demand through our Pharma Grade Sesame Oil Production Database”

• • • Pharma Grade Sesame Oil production database for 24+ countries worldwide
    • Pharma Grade Sesame Oil Powder sales volume for 24+ countries
    • Country-wise Pharma Grade Sesame Oil production capacity and production plant mapping, production capacity utilization for 20+ manufacturers
    • Pharma Grade Sesame Oil production plants and production plant capacity analysis for top manufacturers

Geographical Demand Dynamics in Pharma Grade Sesame Oil Market 

The Pharma Grade Sesame Oil Market shows distinct geographical demand patterns shaped by regional pharmaceutical manufacturing capacities, traditional medicine prevalence, and consumer health trends. For instance, Asia-Pacific leads the demand curve, driven primarily by India and China, which are not only major producers but also huge consumers due to their vast pharmaceutical and herbal medicine industries. India alone contributes significantly to the global market due to widespread application in Ayurveda and modern pharmaceutical injectables, underscoring a growth rate surpassing 7% CAGR in the region. 

North America follows, primarily due to rising demand in parenteral drug formulations and nutraceuticals. The United States, with its expanding contract manufacturing organizations (CMOs) and increasing interest in plant-based pharmaceutical products, is a major hub encouraging steady demand growth. Europe too is notable for its regulatory push toward natural excipients, facilitating uptake of pharma grade sesame oil in drug formulations, herbal medicine, and dietary supplements. 

 

Pharma Grade Sesame Oil Market Production Influenced by Seed Cultivation 

The production landscape of the Pharma Grade Sesame Oil Market is closely tied to sesame seed cultivation, with leading producers shaping the availability and quality of pharma-grade oil. India, Myanmar, and Sudan remain top producers of sesame seeds, supplying raw material for oil extraction. For example, India’s sesame seed output accounts for more than 25% of global production, enabling local manufacturers to meet rising pharmaceutical demand with shorter supply chains and cost advantages. 

Modern advancements in refining and purification technology have allowed several producers in Asia to upgrade oil quality to pharma-grade standards, catering to stringent international market needs. African countries like Sudan and Nigeria are also expanding production capacity with investments aimed at enhancing seed quality and processing infrastructure, opening new supply sources for the global Pharma Grade Sesame Oil Market. 

 

Market Segmentation by Application in Pharma Grade Sesame Oil Market 

The Pharma Grade Sesame Oil Market segmentation by application reveals diversified consumption patterns. The injectable drug segment dominates consumption due to the oil’s safety and efficacy as a carrier solvent for lipophilic drugs. For example, injectable hormone therapies like progesterone and testosterone are predominantly formulated with pharma-grade sesame oil, accounting for nearly 40% of total market consumption. 

The Ayurvedic and herbal medicine segment represents another substantial share, covering oil-based medicinal products used in topical treatments and massage therapies. This segment is expected to grow at 8% CAGR, fueled by escalating global demand for plant-based and traditional medicine products. Additionally, the nutraceutical segment uses pharma-grade sesame oil as a carrier or base for antioxidant and vitamin supplements, showing double-digit growth aligned with rising health awareness globally. 

 

Segmentation by Formulation Type in Pharma Grade Sesame Oil Market 

The Pharma Grade Sesame Oil Market also experiences segmentation by formulation type, primarily injectable and topical preparations. Injectable formulations consume the largest volume, driven by the increasing prevalence of chronic disease treatments requiring oil-based injectables with sustained release characteristics. For instance, oil-soluble vitamins and steroid hormone therapies rely heavily on pharma-grade sesame oil for enhanced bioavailability and stability. 

Topical and massage oil formulations, popular in Ayurvedic and complementary medicine, form the second largest segment. These products capitalize on sesame oil’s anti-inflammatory and antioxidant properties, making them preferred for managing arthritis and muscle pain. Growth in alternative medicine acceptance in Western markets is driving an uptick in topical sesame oil product development within the pharmaceutical-grade category. 

 

Pharma Grade Sesame Oil Price Trends Shaping Market Strategies 

The Pharma Grade Sesame Oil Price Trend has shown a stable but gradually upward trajectory over the past five years, influenced by fluctuations in sesame seed raw material supply and increasing demand in regulated pharmaceutical sectors. For instance, a surge in sesame seed prices in 2023 due to adverse weather in major cultivation zones temporarily pushed pharma-grade sesame oil prices up by nearly 12%. 

However, price volatility has decreased recently as investments in cultivation efficiency and seed quality have increased supply reliability. Importantly, consistent demand from parenteral drug manufacturers has supported a minimum price floor, increasing investor confidence in the market’s growth potential. Datavagyanik notes that evolving quality standards and purification techniques further justify a slightly higher price premium compared to generic oil grades. 

 

Impact of Raw Material Supply on Pharma Grade Sesame Oil Price 

Sesame seed availability is the most critical determinant of the Pharma Grade Sesame Oil Price structure. For example, disruptions in production from India and Myanmar due to climatic disruptions or export restrictions have historically led to sudden price hikes, directly influencing pharma industry procurement costs. 

Producers have responded by diversifying sourcing strategies, incorporating African and South American seed supplies to stabilize input costs. This diversification has helped moderate the Pharma Grade Sesame Oil Price Trend, preventing extreme fluctuations and attracting long-term pharmaceutical buyers seeking price predictability alongside quality compliance. 

 

Regional Price Variations in Pharma Grade Sesame Oil Market 

Regional disparities in pricing also characterize the Pharma Grade Sesame Oil Market, primarily owing to differences in refining capabilities, import tariffs, and supply chain efficiency. For example, pricing in North America is higher due to stricter regulatory requirements and longer logistics chains. European pharmaceutical manufacturers, adhering to high purity norms, accept premium prices, often 15-20% above Asia-Pacific levels. 

Contrastingly, Asia-Pacific markets benefit from local production, allowing competitive pricing and larger volume consumption. India, as both a major producer and consumer, maintains some of the most stable pharma-grade sesame oil prices globally, facilitating high-volume export opportunities to adjoining regions. 

 

Growth Outlook Through Price and Demand Elasticity in Pharma Grade Sesame Oil Market 

Price elasticity in the Pharma Grade Sesame Oil Market remains moderate, given the limited substitutes for pharma applications and the oil’s unique properties. Rising demand from high-value segments such as hormone injectables and Ayurvedic formulations allows manufacturers to pass on moderate price increases without significantly impacting demand. 

Furthermore, ongoing investments in cultivation and refining infrastructure are expected to ease supply constraints, which may moderate the Pharma Grade Sesame Oil Price Trend in the medium term. This combination of steady price growth and demand stability fosters a positive outlook for both producers and pharma end-users, encouraging further market expansion. 

 

Strategic Market Segmentation Across Regions 

The Pharma Grade Sesame Oil Market can be segmented regionally by demand intensity and production capacity. Asia-Pacific holds the largest demand share due to its dual role as producer and consumer, leveraging a mix of traditional and modern pharma sectors. This region is expected to maintain above-average growth rates owing to expanding pharmaceutical manufacturing and rising herbal medicine commercialization. 

In Europe and North America, segmentation trends reflect a premium market focused on stringent quality standards and product innovation. These regions have smaller volume demand but higher value per unit, driven by advanced drug delivery applications and growing consumer preference for natural pharmaceutical excipients. Emerging markets in Latin America and Africa are increasingly important, driven by expanding healthcare infrastructure and agricultural upgrades impacting local pharma-grade sesame oil production. 

 

Pharma Grade Sesame Oil Market Price Trend—Future Projections 

Looking ahead, the Pharma Grade Sesame Oil Price Trend is projected to show a moderate upward trajectory supported by steady demand growth and innovation in processing. For example, ongoing improvements in refining processes that enhance oil stability are expected to justify a sustained premium over generic vegetable oils. 

Moreover, global shifts toward natural and plant-based excipients in pharmaceutical and nutraceutical formulations will drive consistent volume upticks supporting price appreciation. Datavagyanik foresees a balanced market where increased supply through new cultivation areas offsets some pricing pressures, but overall, prices will trend positively aligned with market maturation and expanding application scopes. 

 

 

“Pharma Grade Sesame Oil Manufacturing Database, Pharma Grade Sesame Oil Manufacturing Capacity”

• • • Pharma Grade Sesame Oil top manufacturers market share for 24+ manufacturers
    • Top 5 manufacturers and top 10 manufacturers of Pharma Grade Sesame Oil in North America, Europe, Asia Pacific
    • Production plant capacity by manufacturers and Pharma Grade Sesame Oil production data for 20+ market players
    • Pharma Grade Sesame Oil production dashboard, Pharma Grade Sesame Oil production data in excel format

 

Leading Manufacturers Shaping Pharma Grade Sesame Oil Market 

The Pharma Grade Sesame Oil Market is characterized by several key manufacturers that dominate global production through a combination of high-quality product offerings, strategic distribution networks, and innovative refining methods. These market leaders have solidified their positions by catering to the stringent pharmaceutical standards that the sector demands. Companies such as Cargill Inc., Kankai Oil & Oilseed Mills, Adani Wilmar Ltd., Desai Brothers Pvt. Ltd., and Yunnan Yunling Agricultural Development Co. have emerged as frontrunners in supplying pharma-grade sesame oil worldwide. 

 

Cargill Inc. – A Global Leader in Pharma Grade Sesame Oil Market 

Cargill Inc. stands out as a major player in the Pharma Grade Sesame Oil Market owing to its robust global presence and diversified product portfolio. The company’s pharma-grade sesame oil products are widely used in injectable formulation bases and nutritional supplements. For example, Cargill’s “IQF Pharma Sesame Oil” is specifically refined to meet USP and EP standards, positioning it as a preferred supplier for pharmaceutical formulations that require ultra-purified excipients. 

Cargill’s extensive refining capabilities and investment in high-tech processing plants across Asia and North America allow it to maintain a significant market share, estimated to be approximately 20% globally. This leadership is further amplified by partnerships with pharmaceutical manufacturers and contract development organizations focusing on natural excipients, solidifying their foothold in the market. 

 

Kankai Oil & Oilseed Mills – Specialized Producer for Pharma Applications 

Kankai Oil & Oilseed Mills has a dedicated presence in the Pharma Grade Sesame Oil Market, particularly known for its high-purity sesame oil variants tailored for pharmaceutical and Ayurvedic products. Their “Kankai Pharma Sesame” line boasts rigorous testing and refining, ensuring compliance with international pharmaceutical grading, which makes it a popular choice for manufacturers in South Asia and the Middle East. 

The company’s strategic focus on blending traditional seed sourcing with modern refining technology has earned it a solid market share close to 12%. Moreover, Kankai’s commitment to sustainable and organic sesame sourcing aligns with global demand for clean-label pharmaceutical ingredients, driving consistent growth in specialty pharma-grade oil supply. 

 

Adani Wilmar Ltd. – Expanding Pharma Grade Sesame Oil Market Reach 

Adani Wilmar has rapidly grown within the Pharma Grade Sesame Oil Market by leveraging its extensive oilseed processing infrastructure and distribution strength in Asia-Pacific regions. The manufacturer’s “Fortune Pharma Sesame Oil” is engineered to meet pharmaceutical specifications for injectable and topical applications. Their product line caters not only to domestic pharma companies but also exports to regulated markets such as Europe. 

Adani Wilmar’s integrated supply chain, from seed sourcing to refining, ensures competitive pricing and supply reliability, contributing to a market share estimated at around 15%. Their continuous investments in refining capacity expansion highlight their commitment to further strengthening their presence in pharma-grade oils, positioning them as a major supplier in the evolving market landscape. 

 

Desai Brothers Pvt. Ltd. – Traditional Expertise Meets Pharma Grade Quality 

Desai Brothers, with a foundation based on traditional oil processing, has successfully transitioned into the Pharma Grade Sesame Oil Market by modernizing their production and quality control systems. Their “DB Pharma Sesame Oil” series is popular in both domestic pharmaceutical applications and export markets. The company focuses on stringent quality certifications including ISO and GMP compliance, essential for pharma-grade products. 

With a market share hovering around 10%, Desai Brothers maintains strong customer loyalty through its emphasis on product consistency and supply chain transparency. Their ability to cater to both pharmaceutical and Ayurvedic product manufacturers has helped sustain growth in an increasingly competitive market. 

 

Yunnan Yunling Agricultural Development Co. – Regional Leader with Global Aspirations 

Yunnan Yunling Agricultural Development Co., based in China, plays a pivotal role in the Pharma Grade Sesame Oil Market, primarily supplying pharma-grade oils used in Traditional Chinese Medicine (TCM) and growing pharmaceutical formulations sectors. Their “Yunling Pharma Sesame Oil” product line emphasizes high-purity extraction techniques and organic sesame sourcing to meet both domestic and international pharmacopeial standards. 

China’s rising pharmaceutical manufacturing and TCM export markets have helped Yunling capture an estimated 8% share in pharma-grade sesame oil demand. The company’s vision to expand into Western pharmaceutical markets by enhancing refining technology and international certifications reflects a strategic focus on global market penetration. 

 

Pharma Grade Sesame Oil Market Share by Manufacturers 

Market share distribution within the Pharma Grade Sesame Oil Market reveals a competitive landscape where established multinationals coexist alongside specialized regional producers. The top five players collectively control over 65% of the global market, driven by technological investments, supply chain integration, and product diversification. 

Manufacturer	Estimated Market Share (%)	Key Product Lines
Cargill Inc.	20	IQF Pharma Sesame Oil
Adani Wilmar Ltd.	15	Fortune Pharma Sesame Oil
Kankai Oil & Oilseed Mills	12	Kankai Pharma Sesame
Desai Brothers Pvt. Ltd.	10	DB Pharma Sesame Oil
Yunnan Yunling Agricultural Dev.	8	Yunling Pharma Sesame Oil

This concentration highlights the importance of scale, quality assurance, and regional focus in securing pharma-grade sesame oil contracts globally. Many mid-size manufacturers focus on niche local markets but find it challenging to meet global regulatory demands without extensive investment. 

 

Recent Industry Developments and Market Player Activities 

Several important developments have marked the Pharma Grade Sesame Oil Market in the first half of 2025, underscoring its dynamic nature and evolving opportunities: 

• In March 2025, Cargill Inc. completed the expansion of its sesame oil refining plant in Gujarat, India, increasing pharma-grade production capacity by 25%. This expansion aims to meet increasing demand from the injectable pharmaceutical segment in Asia-Pacific and Europe. 

• Adani Wilmar Ltd. announced a strategic joint venture with a European pharmaceutical excipient company in April 2025, focusing on advancing purification technologies to enhance sesame oil’s pharmaceutical-grade properties and widen its application in clinical drug formulations. 

• Kankai Oil & Oilseed Mills launched an organic pharma-grade sesame oil product line in January 2025, targeting niche markets within the Ayurvedic and natural pharmaceutical sectors. This launch aligns with growing consumer preferences for certified organic excipients. 

• Desai Brothers Pvt. Ltd. received GMP certification for its sesame oil manufacturing facility in February 2025, enabling it to supply major pharmaceutical players in the Middle East and North Africa. This certification is expected to increase its pharma market share substantially over the next 12 months. 

• Yunnan Yunling Agricultural Development Co. signed a distribution agreement in May 2025 with a major North American pharmaceutical distributor, marking its entry into the lucrative Western pharma grade sesame oil market. The agreement focuses on supplying pharma-grade oils suitable for TCM and integrative medicine production. 

 

“Pharma Grade Sesame Oil Production Data and Pharma Grade Sesame Oil Production Trend, Pharma Grade Sesame Oil Production Database and forecast”

• • • Pharma Grade Sesame Oil production database for historical years, 12 years historical data
    • Pharma Grade Sesame Oil production data and forecast for next 8 years